Current status of liver support systems

Clinics in Liver Disease

Volumn 4, Issue 3, 2000, Pages 711-729

  Kaptanoglu, Levent ^b   Blei, Andres T ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LIVER; EXTRACORPOREAL CIRCULATION; HUMAN; LIVER FAILURE; LIVER PERFUSION; LIVER TRANSPLANTATION; MULTIPLE ORGAN FAILURE; REVIEW; TECHNOLOGY;

EID: 0033885183     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70134-3     Document Type: Article

References (106)

1. G.M. Abouna B. Serrou H.G. Beohmig Long-term hepatic support by intermittent multi-species liver perfusions Lancet 2 1970 391 396
2. S. Aggarwal D. Kramer H. Yonas Cerebral hemodynamic and metabolic changes in fulminant liver failure: A retrospective study Hepatology 19 1994 80 87
3. S.R. Ash D.E. Blake D.J. Carr Push-pull sorbent based pheresis for treatment of acute hepatic failure. The biologic-detoxifier/plasma filter system ASAIO J 44 1998 129 139
4. A. Bader E. Knop A. Boker A novel bioreactor design for in vitro reconstruction of in vivo liver characteristics Artif Organs 19 1995 347 352
5. A. Baquerizo A. Mhoyan M. Kearns-Jonker Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment Transplantation 67 1999 5 18
6. S. Bender I.V. Rivera M.D. Norenberg Tumor necrosis factor α induces astrocyte swelling Trans Am Neurochem 23 1992 113
7. P. Berk J.D. Goldberg Charcoal hemoperfusion. Plus Ça change, plus c'est la même chose Gastroenterology 94 1988 1228 1230
8. B. Beutler V. Kruys Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself J Cardiovasc Pharmacol 25 1995 S1 S8
9. D. Bihari A.E. Gimson M. Waterson Tissue hypoxia during fulminant hepatic failure Crit Care Med 13 1985 1034 1039
10. B.M. Bilir D. Guinette F. Karrer Hepatocyte transplantation in acute liver failure Liver Transpl 6 2000 32 40
11. A.T. Blei F.S. Larsen Pathophysiology of cerebral edema in fulminant hepatic failure J Hepatol 31 1999 771 776
12. A.T. Blei Brain edema and intracranial hypertension: a focus for the use of liver support systems Artif Organs 21 1997 1182 1184
13. S.W. Brusilow Inborn errors of urea synthesis J. Lloyd C. Scriver Genetic and Metabolic Disease in Pediatrics 1985 Butterworths London 140 165
14. N.L.R. Bucher G. Robinson S.R. Farmer Effects of extracellular matrix on hepatocytes growth and gene expression. Implications for hepatic regeneration and the repair of liver injury Semin Liver Dis 10 1990 11 19
15. G.W. Byrne K.R. McCurry M.J. Martin Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage Transplantation 63 1997 149 155
16. T.M.S. Chang Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma Lancet 2 1972 1371 1372
17. R.S. Chari B. Collins J.C. Magee Brief report: Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation N Engl J Med 331 1994 234 237
18. S.C. Chen W.R. Hewitt S. Eguchi Prolonged survival in anhepatic pigs treated with a bioartificial liver Surg Forum 47 1996 161 163
19. J.O. Clemmesen F.S. Larsen J. Kondrup Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration Hepatology 29 1999 648 653
20. J. Cordoba A.T. Blei S. Mujais Determinants of ammonia clearance by hemodialysis Artif Organs 20 1996 800 803
21. J. Cordoba J. Crespin J. Gottstein Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis Gastroenterology 116 1999 686 693
22. A. Davenport E.J. Will A.M. Davison Comparison of the use of standard heparin and protacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined renal and hepatic failure Nephron 66 1994 431 437
23. A. Davenport E.J. Will A.M. Davison Continuous vs. intermittent forms of haemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema Contrib Nephrol 93 1991 225 233
24. G.H. De Groot S.W. Schalm I. Schicht Comparison of large-pore membrane haemodialysis and cross-dialysis in acute hepatic insufficiency in pigs Eur J Clin Invest 13 1983 65 71
25. J. Denis P. Opolon M.L. Delorme Long-term extra-corporeal assistance by continuous haemofiltration during fulminant hepatic failure Gastroenterol Clin Biol 3 1979 337 348
26. A. Ellis R.D. Hughes J.A. Wendon Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure Hepatology 24 1996 1446 1451
27. L.M. Flendrig F. Calise E. Di Florio Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver Int J Artif Organs 22 1999 701 708
28. L.M. Flendrig R.A. Chamuleau M.A. Maas Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific α-GST detection to monitor hepatocyte viability J Hepatol 30 1999 311 320
29. D.P. Foley F.J. Vittimberga S.H. Quarfordt Biliary secretion of extracorporeal porcine livers with single and dual vessel perfusion Transplantation 68 1999 362 368
30. L.G. Forni P.J. Hilton Continuous hemofiltration in the treatment of acute renal failure N Engl J Med 336 1997 1303 1309
31. I.J. Fox J.R. Chowdbury S.S. Kaufman Treatment of the Crigler-Najjar syndrome type 1 with hepatocyte transplantation N Engl J Med 338 1998 1422 1426
32. I.J. Fox A.N. Langnas L.W. Fristoe Successful application of extracorporeal liver perfusion: A technology whose time has come Am J Gastroenterol 88 1993 1876 1881
33. B.G. Gazzard B. Portmann M.J. Weston Charcoal haemoperfusion in the treatment of fulminant hepatic failure Lancet 1 1974 1301 1307
34. J.C. Gerlach Development of a hybrid liver support system: A review Int J Artif Organs 19 1996 645 654
35. A.E.S. Gimson S. Braude P.J. Mellon Earlier charcoal haemoperfusion in fulminant hepatic failure Lancet 2 1982 681 683
36. A.E.S. Gimson P.G. Langley R.D. Hughes Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure Lancet 1 1980 173 175
37. E. Gohda H. Tsubouchi H. Nakayama Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure J Clin Invest 81 1988 414 419
38. C.D. Gove R.D. Hughes R. Williams Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure British Journal of Experimental Pathology 63 1982 547 553
39. D Haussinger G Kircheis R Fischer Hepatic encephalopathy in chronic liver disease: a clinical manifestation of low grade cerebral edema? J Hepatol 2000 in press
40. J.H. Hoofnagle R.L. Carithers Jr C. Shapiro Fulminant hepatic failure: Summary of a workshop Hepatology 21 1995 240 252
41. R.D. Hughes A.M. Cochrane A.D. Thomson The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes British Journal of Experimental Pathology 57 1976 348 353
42. R.D. Hughes A. Pucknell D. Routley Evaluation of the biological-DT sorbent-suspension dialyser in patients with fulminant hepatic failure Int J Artif Organs 17 1992 657 662
43. R.D. Hughes H. Yamada C.D. Gove Inhibitors of hepatic DNA synthesis in fulminant hepatic failure Dig Dis Sci 36 1991 816 819
44. T. Hui J. Rozga A.A. Demetriou Bioartificial liver treatment for patients with fulminant hepatic failure: The Cedars-Sinai Medical Center experience V. Arroyo J. Bosch M. Bruguera Treatment of Liver Diseases 1999 Masson Barcelona 137 150
45. H. Iwai M. Nagaki T. Naito Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure Crit Care Med 26 1998 873 876
46. R. Jalan S.W.M. Olde Dalmink A. Lee Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure Lancet 354 1999 1164 1168
47. H.O. Jauregui The technology of biological extracorporeal liver assist devices: from infancy to adolescence Artif Org 21 1997 1163 1168
48. J.H. Kelly N.L. Sussman The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure ASAIO J 40 1994 83 85
49. W.M. Keynes Haemodialysis in the treatment of liver failure Lancet 2 1968 1236 1238
50. J.E. Kiley J.C. Pender H.F. Welch Ammonia intoxication treated by hemodialysis N Engl J Med 259 1958 1156 1161
51. S. Klammt J. Stange S.R. Mitzner Changes of prognostic and clinical scoring systems in liver failure by albumin dialysis (MARS) Hepatology 30 1999 163A
52. H.G. Koebe C. Dahnhardt J. Muller-Hocker Cryopreservation of porcine hepatocyte cultures Cryobiology 33 1996 127 141
53. J. Kondrup T. Almdal H. Vilstrup High volume plasma exchange in fulminant hepatic failure Int J Artif Organs 15 1992 669 676
54. S.B. Kong S. Chen A.A. Demetriou Matrix-induced liver cell aggregates (MILCA) for bioartificial liver use Int J Artif Organs 18 1996 43 49
55. B.K. Kreymann M. Seige U. Schweigart Albumin dialysis: Effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins J Hepatol 31 1999 1080 1085
56. F.S. Larsen E. Ejlersen B.A. Hansen Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption Eur J Gastroenterol Hepatol 7 1995 887 892
57. F.S. Larsen B.A. Hansen E. Ejlersen Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure J Hepatol 23 1995 212 217
58. F.S. Larsen B.A. Hansen E. Ejlersen Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume paracentesis in fulminant hepatic failure Eur J Gastroenterol Hepatol 8 1996 261 265
59. F.S. Larsen B.A. Hansen L.G. Jorgensen High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure Transplant Proc 26 1994 1788
60. M.J. Lepore A.J. Martel Plasmapheresis with plasma exchange in hepatic coma: Methods and results in five patients with acute fulminant hepatic necrosis Ann Intern Med 72 1970 165 174
61. J. Licinio M.L. Wong Pathways and mechanisms for cytokine signaling of the central nervous system J Clin Invest 100 1997 2941 2947
62. T.S. Lie H.J. Dengler A. Gutgemann [Extracorporeal perfusion with baboon liver in treatment of hepatic coma (author's translation)] Dtsch Med Wochenschr 102 1977 1506 1511
63. J.C. Lopez-Talavera G. Cadelina J. Olchowski Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats Hepatology 23 1996 1616 1621
64. S. Master J. Gottstein A.T. Blei Cerebral blood flow and the development of ammonia-induced brain edema in rats after portacaval anastomosis Hepatology 30 1999 876 880
65. S. Matsubara K. Okabe K. Ouchi Continuous removal of middle molecules by hemofiltration in patients with acute liver failure Crit Care Med 18 1990 1331 1337
66. L.P. McChesney E.A. Fagan D.L. Rowell Extracorporeal liver perfusion Lancet 353 1999 120 121
67. J.R. McConnell D.L. Antonson C.S. Ong Proton spectroscopy of brain glutamine in acute liver failure Hepatology 22 1995 69 74
68. B.E. McLaughlin C.M. Tosone L.M. Custer Overview of extracorporeal liver support systems and clinical results Ann NY Acad Sci 875 1999 310 325
69. Y. Miwa P.M. Harrison F. Farzaneh Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure J Hepatol 7 1997 780 788
70. Y. Muto K.T. Nouri-Aria A. Meager Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure Lancet 9 1988 72 74
71. N. Nagasue H. Yukaya H. Ogawa Human liver regeneration after major hepatic resection: A study of normal livers and livers with chronic hepatitis and cirrhosis Ann Surg 206 1987 30 39
72. F. Nomura K. Ohnishi H. Terabayashi Effect of portal-systemic shunting on hepatic ammonia extraction in patients with cirrhosis Hepatology 20 1994 1478 1481
73. J. O'Grady A.E.S. Gimson C.J. O'Brien Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure Gastroenterology 94 1988 1186 1192
74. J.G. O'Grady G.L. Alexander K.M. Haylar Early indicators of prognosis in fulminant hepatic failure Gastroenterology 97 1989 439 445
75. K.J. Oldhafer A. Bornscheuer N.R. Fruhauf Rescue hepatectomy for initial graft non-function after liver transplantation Transplantation 67 1999 1024 1028
76. J.D. Opolon V. Nusinovici A. Granger Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane Gut 19 1978 787 793
77. C. Patience Y. Takeuchi R.A. Weiss Infection of human cells by an endogenous retrovirus of pigs Nat Med 3 1997 282 286
78. Z. Pitkin C. Mullon Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system Artif Organs 23 1999 828 833
79. T.M. Rahman H.J.F. Hodgson Review article: Liver support systems in acute hepatic failure Aliment Pharmacol Ther 13 1999 1255 1272
80. J. Rakela S.B. Kurtz J.T. McCarthy Postdilution hemofiltration in the management of acute hepatic failure: A pilot study Mayo Clin Proc 63 1988 113 118
81. A.G. Redeker H.S. Yamahiro Controlled trial of exchange-transfusion therapy in fulminant hepatitis Lancet 1 1973 3 6
82. S. Riordan R. Williams Bioartificial liver support: developments in hepatocyte culture and bioreactor design Br Med Bull 53 1997 730 744
83. C. Rust G.J. Gores Hepatocyte transplantation in acute liver failure: A new therapeutic option for the next millennium? Liver Transpl 6 2000 41 43
84. D. Samuel P. Ichai C. Féray Treatment of patients with fulminant hepatitis with a bioartificial liver before transplantation Hepatology 27 1997 252A
85. Y. Sato K. Tsukada Y. Matsumoto Interferon-gamma inhibits liver regeneration by stimulating major histocompatibility complex class II antigen expression by regenerating liver Hepatology 18 1993 340 346
86. F.V. Schiodt E. Atillasoy A.O. Shakil Etiology and outcomes for 295 patients with acute liver failure in the United States Liver Transpl Surg 5 1999 86 89
87. F. Schneider P. Lutun K. Boudjema In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure Hepatology 19 1994 38 44
88. J.K. Schumacher T. Okamoto B.H. Kim Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy Hepatology 24 1996 337 343
89. K.D. Sekiyama M. Yoshiba A.W. Thomson Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis Clin Exp Immunol 98 1994 71 77
90. D.B. Silk P.N. Trewby R.A. Chase Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis Lancet 2 1977 1 3
91. J. Stange S. Mitzner Cell sources for bioartificial liver support Int J Artif Organs 19 1996 14 17
92. J. Stange S.R. Mitzner T. Risler Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support Artif Organs 23 1999 319 330
93. S.C. Strom R.A. Fisher M.T. Thompson Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure Transplantation 63 1997 559 569
94. N.L. Sussman G. Gisalon C.A. Conlin The hepatix extracorporeal liver assist device; initial clinical experience Artif Organs 18 1994 390 396
95. R. Taub L.E. Greenbaum Y. Peng Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration Semin Liv Dis 19 1999 117 127
96. A.A. te Velde L.M. Flendrig N.C.J.J. Ladiges Possible immunological problems of bioartificial liver support Int J Artif Organs 20 1997 418 421
97. C. Trey D.G. Burns S.J. Sanders Treatment of hepatic coma by exchange blood transfusion N Engl J Med 274 1966 473 481
98. B.A. Vogels M.A. Maas A. Bosma Significant improvement of survival by intrasplenic hepatocyte transplantation in totally hepatectomized rats Cell Transpl 5 1996 369 378
99. F.D. Watanabe C. Mullon W.R. Hewitt Clinical experience with a bioartificial liver in the treatment of severe liver failure Ann Surg 225 1997 484 494
100. R. Wiest R. Groszman Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance Semin Liver Dis 19 1999 411 426
101. C.F.W. Wolf B.E. Munkelt Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries ASAIO Trans 21 1975 16 26
102. N. Yanai M. Suzuki M. Obinata Hepatocyte cell lines established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene Exp Cell Res 197 1991 50 56
103. M. Yosiba K. Inoue K. Sekiyama Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure Artif Org 20 1996 1169 1172
104. M. Yoshiba K. Sekiyama Y. Iwamura Development of reliable artificial liver support (ALS)-Plasma exchange in combination with hemodiafiltration using high-performance membranes Dig Dis Sci 38 1993 469 476
105. F.J. Zieve L. Zieve W.M. Doizaki Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma J Pharmacol Exp Ther 191 1974 10 16
106. L. Zieve M. Shekleton C. Lyftogt Ammonia, octanate and a mercaptan depress regeneration of normal rat liver after partial hepatectomy Hepatology 5 1985 28 31